10.1016/j.amjmed.2019.04.027 158
Opportunities Expanding Use in Obesity Management The growing use of GLP-1 analogues for the treatment of obesity is one of the largest opportunities
The poll conducted by Leger Healthcare says more than half of the people surveyed who are taking the medications reported decreased appetite and 40 per cent said they have fewer food cravings
Dimensions: 4372 x 2906 px | 37 x 24.6 cm | 14.6 x 9.7 inches | 300dpi Date taken: 19 September 2010 Photographer: MALLET Jean-Franois / Hemis.fr
Ravina CG, Chang CI, Tsakraklides GP, McDermott JP, Vega JM, Leustek T, Gotor C, Davies JP (2002) The sac mutants of Chlamydomonas reinhardtii reveal transcriptional and posttranscriptional control of cysteine biosynthesis
Injections are often medically necessary for people with Crohns disease, Celiac disease, or those who have undergone bariatric surgery